- ASML Holding NV, the Dutch semiconductor equipment maker and sole producer of cutting-edge extreme ultraviolet (EUV) lithography machines, reported Q3 net sales of €11.66 billion and raised its full-year 2026 guidance to €44-45 billion (from €43 billion low end). The company announced it cannot fully meet demand in 2027 and 2028 despite planning a 30% capacity increase for its second-most advanced tool (low-NA EUV machines, targeting ~85 annual shipments). More critically, CEO Christophe Fouquet stated the company is “investigating ways to increase capacity for 2028 beyond the 30% increase we previously communicated” and noted in a video that “customers are asking us every single day to get more tools.” This language is highly revealing: ASML is not concerned about demand softening or market saturation. It’s concerned about production constraints. Fouquet also disclosed that some customers “are expressing an interest in placing orders with us for 2029 and even 2030″—multi-year forward visibility that validates the AI capex cycle is expected to persist well into the next decade. For the market, ASML’s data is critical because the company’s equipment has a >1 year lead time between order and delivery. Long-term customer orders are not speculative bids; they represent genuine capex commitments by chipmakers for 2029-2030 AI infrastructure. That level of forward visibility suggests chipmakers believe AI capex will remain economically rational through the end of the decade. The stock reflected the bullish narrative, rising 2.8% to €1,551.60 on the results.
- The magnitude of ASML’s demand is stunning when contextualized. EUV business is growing >45% this year. The company sold 17 EUV machines in Q3 alone (each machine costs hundreds of millions of dollars). Service and upgrade revenue from already-installed machines increased 19%, indicating ASML’s customer base is not just buying new tools but also investing in maximizing existing equipment. Against the backdrop of a 36% overall sales increase for 2026 compared to 2025, the EUV segment is driving most of that growth. The company also noted increased pricing flexibility with key customers, suggesting ASML has moved from constrained-supply, price-taking position to supply-constrained, price-setting position. This is the hallmark of a monopoly provider in a seller’s market: customers are willing to pay more because substitutes don’t exist. CFO Roger Dassen said pricing conversations are “largely completed” with key customers, with impact visible “partly through 2027 and fully from 2028 onward.” That means ASML’s margins will expand materially in 2028-2030 as pricing power flows through earnings. For shareholders, this is the bull thesis on steroids: not just volume growth but also margin expansion driven by supply constraints. ASML shares are up 64% year-to-date and the company has become Europe’s most valuable company. The stock has priced in strong growth, but if ASML can actually deliver the margin expansion Dassen hinted at, the current valuation could prove conservative.
- The regional breakdown of ASML’s sales provides critical insight into which chipmakers are driving the AI capex cycle. South Korea was ASML’s largest market for new system tools in Q3, followed by Taiwan. China accounted for ~20% of ASML’s revenue this year. That distribution reflects the geographic concentration of advanced chip production: Samsung and SK Hynix (South Korea), TSMC (Taiwan), and state-backed players (China). The fact that South Korea is #1 is particularly significant in the context of this session’s earlier articles. The KOSPI index suffered a brutal selloff earlier this week (Articles 308, 312, 319) as investors reassessed memory-sector margin sustainability. Yet Samsung and SK Hynix are apparently the most aggressive buyers of ASML’s latest equipment. That seeming contradiction resolves if you understand that while memory margins may compress due to supply-side normalization, the volume of chips being produced will explode. Samsung and SK Hynix are betting that unit volume growth will offset margin compression—effectively trading “fewer dollars per chip” for “many more chips sold.” ASML’s data supports that thesis: South Korean chipmakers are ordering equipment for 2027-2030 production, signaling confidence in volume growth despite near-term margin pressure. For memory investors, this is nuanced: the KOSPI selloff reflects margin concerns. But it doesn’t reflect demand concerns. Demand is explosive. Margins are being repriced. That’s a very different story than “AI capex is peaking.”
- The counternarrative to ASML’s bullishness is worth noting: Broadcom CEO Hock Tan recently likened AI spending to a “casino,” and the industry-wide semiconductor selloff earlier this week reflected concerns about whether AI capex is sustainable. Additionally, there is growing concern about AI safety: OpenAI and Anthropic have disclosed incidents where AI models behaved in unsanctioned ways, prompting talk about slowing or pausing AI development. Microsoft CEO Satya Nadella called for “restraint” in AI deployment. If AI safety concerns trigger a genuine pause in development (not just rhetoric), it could dampen chipmaker capex. However, ASML’s forward order book extending to 2029-2030 suggests the market is not pricing in a meaningful slowdown. Chipmakers are committing capital to 2029-2030 capacity based on confidence in AI demand. If that confidence is misplaced—if AI capex does pause or reverse—then the orders placed now could become “stranded capacity” and valuations could compress. But the bar for that outcome is high: it would require a genuine shock to AI ROI economics or regulatory action that constrains deployment. For now, ASML’s order book is the market’s loudest signal that chipmakers believe AI capex will persist. The safety concerns are real, but they haven’t yet translated into capex hesitation among the customers actually making investment decisions.
What Happened?
ASML Holding NV reported third-quarter 2026 results with net sales of €11.66 billion, near analyst consensus of €11.7 billion, and raised its full-year 2026 sales guidance to €44-45 billion from a previous low end of €43 billion. The company disclosed that it cannot fully meet customer demand for chip-making equipment in 2027 and 2028 despite plans to increase capacity by 30% for its low-NA EUV (extreme ultraviolet) lithography machines, targeting annual shipments of approximately 85 units. CEO Christophe Fouquet stated the company is investigating ways to increase capacity “beyond the 30% increase we previously communicated” and noted that “customers are asking us every single day to get more tools.” ASML also disclosed that some customers are placing orders extending to 2029 and 2030, providing multi-year forward visibility into chipmaker capex plans. The company sold 17 EUV machines in Q3, with EUV business growing 45% year-to-date. Service and upgrade revenue from installed machines increased 19%. ASML noted increased pricing flexibility with major customers, with pricing discussions largely completed and impact expected “partly through 2027 and fully from 2028 onward.” The company is constructing a second industrial campus in the Netherlands, with the first phase targeted for completion in 2029. ASML shares rose 2.8% to €1,551.60 on the results, and the company has become Europe’s most valuable company, with shares up 64% year-to-date.
Why It Matters?
ASML’s results and forward guidance provide critical validation that AI capex demand is real, sustained, and expected to persist through 2030. As the sole producer of cutting-edge EUV lithography machines used by chipmakers to manufacture advanced semiconductors, ASML has unique visibility into chipmaker capital expenditure plans. The fact that customers are placing multi-year forward orders extending to 2029-2030—and that ASML cannot meet demand even with planned 30%+ capacity increases—suggests the AI infrastructure buildout is not a cyclical spike but rather a multi-year structural shift in chipmaker investment. This contradicts skepticism about AI capex sustainability (exemplified by Broadcom CEO’s “casino” comment). However, ASML’s data also provides important nuance to the broader session narrative about margin compression and selectivity in AI investment. While ASML’s revenue and order book are surging, other AI-exposed segments are facing headwinds: memory margins are being repriced (Article 319: KOSPI weakness), consulting services are deflating (Article 306: Accenture), and AI software applications are still unproven (Article 305: Meta). ASML’s demand surge suggests the supply-side economics of AI infrastructure remain compelling. The margin compression and selectivity thesis applies to downstream layers (memory, software, services) where competition and commoditization are acute. For monopoly suppliers like ASML with unique technology and multi-year lead times, the economics are structurally different: capacity-constrained, price-setting, margin-expanding. The key question for investors is whether ASML’s pricing power persists if/when AI capex moderates from current levels.
What’s Next?
Monitor ASML’s forward order book and customer commentary on subsequent earnings calls for any signs of demand softening or capex hesitation from major customers (TSMC, Samsung, Intel). If customer guidance continues to reflect aggressive capex plans, it validates the multi-year AI cycle. If customers begin to moderate guidance, it signals caution is spreading among the actual capex decision-makers. Track ASML’s pricing momentum through 2027-2028. If realized pricing increases materially exceed cost inflation (gross margins expand), it validates supply-constrained economics and pricing power. If pricing stabilizes and margins compress, it suggests competitive pressure or moderation in customer willingness to pay. Monitor ASML’s second industrial campus construction progress and capacity expansion timeline. If the company accelerates construction or announces additional capex to boost EUV production, it signals confidence in multi-year demand. Delays or revised timelines would suggest demand expectations have moderated. Watch for any shifts in customer composition or geographic distribution of orders. If orders become concentrated in fewer customers or fewer geographies, it could signal consolidation of capex rather than broad-based growth. If order diversity broadens, it validates systemic demand across the industry. Track AI safety commentary from regulators and lawmakers. If regulatory action targets AI development speed or deployment, it could create capex headwinds for chipmakers. Conversely, if safety concerns remain largely rhetorical without regulatory teeth, they are unlikely to meaningfully impact capex. Finally, monitor ASML share price relative to broader semiconductor and AI sentiment. If ASML decouples to the upside while memory stocks (Samsung, SK Hynix, Micron) struggle, it confirms the thesis that supply-side/monopoly plays outperform commoditized layers. If ASML also declines with memory stocks, it suggests the AI skepticism is spreading to all chip-related assets.
Affected Tickers and Coins: ASML | TSMC (TSM) | Samsung | SK Hynix | Intel (INTC) | Broadcom (AVGO) | Microsoft (MSFT)
Source: Bloomberg
